
Yodawy
Yodawy is a technology company.
Financial History
Yodawy has raised $25.0M across 3 funding rounds.
Frequently Asked Questions
How much funding has Yodawy raised?
Yodawy has raised $25.0M in total across 3 funding rounds.

Yodawy is a technology company.
Yodawy has raised $25.0M across 3 funding rounds.
Yodawy has raised $25.0M in total across 3 funding rounds.
Yodawy is a healthcare technology company founded in 2018 and headquartered in Giza, Egypt, that builds a digital platform to simplify access to medications, making them easy and affordable for patients.[1][2][4] It offers B2B pharmacy benefits management and delivery services for insurers and corporates, a B2C e-pharmacy app serving around 150,000 patients monthly, and micro-insurance solutions for uninsured chronic patients, supported by a network of 3,000 partner pharmacies across 38 cities and over 4 million prescriptions processed.[1][2][4] The platform integrates doctors, insurers, and pharmacies to streamline prescriptions for acute and chronic conditions, automates insurance claims, handles supply chain logistics, and provides data analytics for better adherence and availability.[1][4][5]
With reported revenue of 105M EGP and partnerships with 15 insurance companies and 200 corporates—including leading multinationals—Yodawy demonstrates strong growth momentum in Egypt's healthcare sector, processing 100k API requests daily and expanding delivery via its own dispensary and marketplace pharmacies.[1][4]
Yodawy was founded in 2018 by Karim Khashaba (CEO), Sherief El-Feky, and Yasser AbdelGawad in Egypt, addressing inefficiencies in medication access, supply chains, and insurance claims in a fragmented healthcare market.[1][3][5] The idea emerged from leveraging technology to integrate healthcare stakeholders—doctors, insurers, pharmacies—and overcome challenges like stockouts and handwritten prescriptions, starting with an app for instant pharmacy delivery of medicines and cosmetics.[4][5] Early traction came from building a nationwide network, automating e-prescriptions and claims, and scaling to B2B services for payers, which quickly positioned it as a key player, evidenced by partnerships with major insurers and corporates shortly after launch.[1][2][4]
Yodawy rides the digital health wave in emerging markets like Egypt, where fragmented supply chains, low insurance penetration, and urban congestion hinder medication access, capitalizing on rising smartphone adoption and demand for telemedicine/pharmacy tech.[1][2][5] Timing aligns with post-2018 healthtech boom, accelerated by COVID-19 needs for contactless delivery and claims processing, positioning it amid market forces like insurer digitization and chronic disease prevalence in MENA.[1][4] It influences Egypt's ecosystem by enhancing pharmacy revenues, payer efficiencies, and patient outcomes—processing millions of prescriptions—while pioneering sustainable logistics (e.g., EV fleet for Cairo deliveries) to cut costs/emissions, supporting local SMEs and cleaner air in polluted hubs.[2]
Yodawy is poised for regional expansion beyond Egypt, scaling its pharmacy network and micro-insurance amid growing VC interest in MENA healthtech, with trends like AI-driven personalization, full EV logistics, and deeper insurer integrations shaping its path.[1][2][4] Potential challenges include regulatory hurdles and competition, but its 105M revenue, vast partner base, and data moat suggest sustained leadership in accessible healthcare. As a 2018 pioneer simplifying medication access, Yodawy exemplifies how tech bridges Egypt's healthcare gaps, promising broader impact as digital adoption surges.[1][2]
Yodawy has raised $25.0M in total across 3 funding rounds.
Yodawy's investors include Advent Life Sciences, Canyon Creek, Draper Associates, DX Ventures, F-Prime Capital Partners, Global Ventures, Maverick Capital, NEO, One Planet Group, Pitbull Ventures, Questa Capital, Think + Ventures.
Yodawy has raised $25.0M across 3 funding rounds. Most recently, it raised $16.0M Series B in February 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2023 | $16.0M Series B | Advent Life Sciences, Canyon Creek, Draper Associates, DX Ventures, F-Prime Capital Partners, Global Ventures, Maverick Capital, NEO, One Planet Group, Pitbull Ventures, Questa Capital, Think + Ventures, YLEM, Curtis Chambers, Farhad Mohit, Russell Cook, Scott Banister | |
| Jul 1, 2021 | $8.0M Series B | Algebra Ventures, Antler, OMERS Ventures, Esther Dyson | |
| Nov 1, 2019 | $1.0M Series A | Algebra Ventures, Antler, OMERS Ventures, Esther Dyson |